

Sun Pharma to Declare Q4 Results on May 22, 2025
Sun Pharmaceutical Industries will announce results for the fourth quarter ended March 31, 2025, on May 22, 2025. The Company will conduct an hour-long call at 06.30 pm IST on May 22, 2025, where senior management will discuss the Company’s performance and answer questions from participants. To participate in this conference call, please pre-register yourself on the below link and dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, d..

Tata Steel Posts Rs 258.02 Bn Consolidated EBITDA for FY2025
Tata Steel reported a consolidated EBITDA of Rs 258.02 billion for FY2025, reflecting a 10 per cent year-on-year growth despite a challenging operating environment. The company’s consolidated annual revenues stood at Rs 2.18 trillion, with an EBITDA margin of approximately 12 per cent. In India, Tata Steel achieved its highest-ever crude steel production of around 21.7 million tons and record deliveries of about 20.9 million tons, aided by the 5 MTPA expansion at Kalinganagar and full-capacity operations at Neelachal Ispat Nigam. Indian operations contributed Rs 1.33 trillion in revenue and ..

JM Financial Posts Q4FY25 Revenue of Rs 10.27 Bn, PAT at Rs 2.10 Bn
While approving the financial results for the last quarter and financial year ended March 31, 2025, the Board of Directors has recommended a dividend of Rs 2.7/- per share (face value of Re 1/-).Commenting on the results and financial performance, Vishal Kampani, Vice Chairman and Managing Director, JM Financial, said, “The pipeline of capital market & M&A transactions continues to remain strong. We continue to build and scale our wealth and asset management businesses. We have increased our shareholding in JM Financial Credit Solutions Limited to ~97 per cent from ~47 per cent. We w..